This year, about $1.5 billion has landed in state and local government coffers from court settlements made with more than a dozen companies that manufactured, sold, or distributed prescription painkillers and were sued for their role in fueling the opioid crisis.
#WCLC24 roundup: ArriVent thinks its drug can fill Tagrisso’s gaps; Boehringer, Bayer’s data in HER2-mutated lung cancer
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
September 10, 2024